AIM ImmunoTech logo

AIM ImmunoTech (AIM) Q1 2026 Earnings

AIM·Reported May 15, 2026·Before market open

AIM ImmunoTech reported Q1 2026 revenue of $22.0K (+37.5% YoY), beat analyst consensus of $11.0K by $11.0K. Diluted EPS came in at $-0.69 (+86.2% YoY), beat the $-1.08 consensus by $0.39.

Revenue
$22.0Kbeat by $11.0K
Consensus: $11.0K
Diluted EPS
$-0.69beat by $0.39
Consensus: $-1.08
SEC

SEC Filings

Earnings release8-K · 0001493152-26-022499
Quarterly report10-Q · 0001493152-26-023750

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about AIM ImmunoTech's Q1 2026 earnings report.

AIM ImmunoTech (AIM) reported Q1 2026 earnings on May 15, 2026 before market open.

AIM ImmunoTech reported revenue of $22.0K and diluted EPS of $-0.69 for Q1 2026.

Revenue beat the consensus estimate of $11.0K by $11.0K. EPS beat the consensus estimate of $-1.08 by $0.39.

Compared to the same quarter a year prior, revenue grew 37.5% from $16.0K a year earlier and diluted EPS grew 86.2% from $-5.00.

You can read the 8-K earnings release (0001493152-26-022499) and the 10-Q periodic report (0001493152-26-023750) directly on SEC EDGAR. The filing index links above go to sec.gov.